Page 69 - 《精细化工》2021年第8期
P. 69
第 8 期 窦 翔,等: pH 响应虾青素羧甲基壳聚糖微球的制备与应用 ·1563·
[7] TAKUJI T, YUKIO M, MASUMI S, et al. Chemoprevention of [20] SU F Y, LIN K J, SONAJE K, et al. Protease inhibition and
mouse urinary bladder carcinogenesis by the naturally occurring absorption enhancement by functional nanoparticles for effective oral
carotenoid astaxanthin[J]. Carcinogenesis, 1994, (1): 15-19. insulin delivery[J]. Biomaterials, 2012, 33(9): 2801-2811.
[8] NAGENDRAPRABHU P, SUDHANDIRAN G. Astaxanthin inhibits [21] LUEEN H L, LEEUW B J D, LANGEMEER M W E, et al.
tumor invasion by decreasing extracellular matrix production and Mucoadhesive polymers in peroral peptide drug delivery. Ⅵ .
induces apoptosis in experimental rat colon carcinogenesis by carbomer and chitosan improve the intestinal absorption of the
modulating the expressions of ERK-2, NFkB and COX-2[J]. peptide drug buserelin in vivo[J]. Pharmaceutical Research, 1996,
Investigational New Drugs, 2011, 29(2): 207-224. 13(11): 1668-1672.
[9] YASUI Y, HOSOKAWA M, MIKAMI N, et al. Dietary astaxanthin [22] TOZAKI H, ODORIBA T, FUJITA T, et al. Colon delivery of
inhibits colitis and colitis-associated colon carcinogenesis in mice via anti-inflammatory drugs accelerates healing of TNBS induced-colitis
modulation of the inflammatory cytokines[J]. Chemico-Biological in rats[J]. Drug Delivery System, 1998, 13(3): 165-171.
Interactions, 2011, 193(1): 79-87. [23] ZHOU G, ZHANG J, TAI J, et al. Comparison of chitosan
[10] ZHANG X, ZHAO W E, HU L, et al. Carotenoids inhibit proliferation microsphere versus O-carboxymethyl chitosan microsphere for drug
and regulate expression of peroxisome proliferators-activated receptor delivery systems[J]. Journal of Bioactive and Compatible Polymers,
gamma (PPARγ) in K562 cancer cells[J]. Archives of Biochemistry & 2017, 32(5): 469-486.
Biophysics, 2011, 512(1): 96-106. [24] SHARIATINIA Z. Carboxymethyl chitosan: Properties and biomedical
[11] SONG X D, ZHANG J J, WANG M R, et al. Astaxanthin induces applications[J]. International Journal of Biological Macromolecules,
mitochondria-mediated apoptosis in rat hepatocellular carcinoma 2018, 120: 1406-1419.
CBRH-7919 cells[J]. Biological & Pharmaceutical Bulletin, 2011, [25] YI Y (易喻), JIANG W (江威), WANG H (王鸿), et al. Study on
34(6): 839-844. preparation and the performance of the carboxymethyl chitosan[J].
[12] SONG X D, WANG M R, ZHANG L X, et al. Changes in cell Journal of Zhejiang University of Technology (浙江工业大学学报),
ultrastructure and inhibition of JAK1/STAT3 signaling pathway in 2011, 39(1): 16-20.
CBRH-7919 cells with astaxanthin[J]. Toxicol Mech Methods, 2012, [26] LEE J S, PARK S A, CHUNG D, et al. Encapsulation of
22(9): 679-686. astaxanthin-rich Xanthophyllomyces dendrorhous for antioxidant
[13] ZHAO L Y, ZHAO G H, CHEN F, et al. Different effects of delivery[J]. International Journal of Biological Macromolecules,
microwave and ultrasound on the stability of (all-E)-astaxanthin[J]. 2011, 49(3): 268-273.
Journal of Agricultural and Food Chemistry, 2006, 54(21): 8346-8351. [27] NIIZAWA I, ESPINACO B Y, ZORRILLA S E, et al. Natural
[14] AFFANDI M, JULIANTO T, MAJEED A. Enhanced oral bioavailability astaxanthin encapsulation: Use of response surface methodology for
of astaxanthin with droplet size reduction[J]. Food Science & the design of alginate beads[J]. International Journal of Biological
Technology Research, 2012, 18(4): 549-554. Macromolecules, 2019, 121: 601-608.
[15] MERCKE O J, LIGNELL A, PETTERSSON A, et al. Oral [28] MURYETI, BUDIMULYANI E, SINURAT E. Adsorption of carbon
bioavailability of the antioxidant astaxanthin in humans is enhanced black using carboxymethyl chitosan in deinking process[C]//International
by incorporation of lipid based formulations[J]. European Journal of Conference on Chemistry, Chemical Process and Engineering, 2017,
Pharmaceutical Sciences, 2003, 19(4): 299-304. 1832: 020038.
[16] AMBATI R R, PHANG S M, RAVI S, et al. Astaxanthin: Sources, [29] HU F B, LIU W K, YAN L L, et al. Optimization and characterization
extraction, stability, biological activities and its commercial of poly(lactic-co-glycolic acid) nanoparticles loaded with astaxanthin
applications—A review[J]. Marine Drugs, 2014, 12(1): 128-152. and evaluation of antiphotodamage effect in vitro[J]. Royal Society
[17] TACHAPRUTINUN A, UDOMSUP T, LUADTHONG C, et al. Open Science, 2019, 6(10): 191184.
Preventing the thermal degradation of astaxanthin through [30] YUAN C, JIN Z Y, XU X M, et al. Preparation and stability of the
nanoencapsulation[J]. International Journal of Pharmaceutics, 2009, inclusion complex of astaxanthin with hydroxypropyl-b-cyclodextrin[J].
374(1/2): 119-124. Food Chemistry, 2008, 109(2): 264-268.
[18] PAVINATTO A, DELEZUK J A M, SOUZA A L, et al. Experimental [31] GOMEZ-ESTACA J, COMUNIAN T A, MONTERO P, et al.
evidence for the mode of action based on electrostatic and Encapsulation of an astaxanthin-containing lipid extract from shrimp
hydrophobic forces to explain interaction between chitosans and waste by complex coacervation using a novel gelatin-cashew gum
phospholipid Langmuir monolayers[J]. Colloids & Surfaces B: complex[J].Food Hydrocolloid, 2016, 61: 155-162.
Biointerfaces, 2016, 145: 201-207. [32] TACHAPRUTINUN A, UDOMSUP T, LUADTHONG C, et al.
[19] DODANE V, KHAN M A, MERWIN J R. Effect of chitosan on Preventing the thermal degradation of astaxanthin through
epithelial permeability and structure[J]. International Journal of nanoencapsulation[J]. International Journal of Pharmaceutics, 2009,
Pharmaceutics, 1999, 182(1): 21-32. 374(1/2): 119-124.